{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:08:33Z","timestamp":1788880113478,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["94-04-30-31245"],"award-info":[{"award-number":["94-04-30-31245"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.biopha.2016.04.026","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T10:10:35Z","timestamp":1461665435000},"page":"295-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Antidepressant effect of pramipexole in mice forced swimming test: A cross talk between dopamine receptor and NMDA\/nitric oxide\/cGMP pathway"],"prefix":"10.1016","volume":"81","author":[{"given":"Sattar","family":"Ostadhadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Imran Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Norouzi-Javidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad-Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2016.04.026_bib0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2016.04.026_bib0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00002826-199310000-00002","article-title":"Neurobiological mechanisms involved in antidepressant therapies","volume":"16","author":"Briley","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.biopha.2016.04.026_bib0015","doi-asserted-by":"crossref","DOI":"10.1097\/00004850-199403001-00004","article-title":"Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)","author":"Hyttel","year":"1994","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2016.04.026_bib0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.euroneuro.2005.12.002","article-title":"Dopaminergic-based pharmacotherapies for depression","volume":"16","author":"Papakostas","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jad.2004.12.010","article-title":"Dopaminergic mechanism of antidepressant action in depressed patients","volume":"86","author":"Willner","year":"2005","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","article-title":"The role of dopamine in the mechanism of action of antidepressant drugs","volume":"405","author":"D'Aquila","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2016.04.026_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0925-4927(99)00009-8","article-title":"Dopamine D 2 receptor binding before and after treatment of major depression measured by [123 I] IBZM SPECT","volume":"90","author":"Klimke","year":"1999","journal-title":"Psychiatry Res.: Neuroimaging"},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0040","first-page":"107","article-title":"Antidepressant-like effect of selective dopamine D 1 receptor agonists in the behavioural despair animal model of depression","volume":"262","author":"Paolo","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2016.04.026_bib0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2004.09.057","article-title":"Involvement of dopamine receptors in the anti- immobility effects of dopamine re-uptake inhibitors in the forced swimming test","volume":"504","author":"Yamada","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s002130100836","article-title":"Is dopamine implicated in the antidepressant- like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?","volume":"159","author":"Renard","year":"2001","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2016.04.026_bib0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(88)90107-0","article-title":"Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity","volume":"148","author":"Borsini","year":"1988","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-3057(95)02131-0","article-title":"Indirect dopamine agonists effects on despair test: dissociation from hyperactivity","volume":"54","author":"Vaugeois","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.biopha.2016.04.026_bib0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","article-title":"Pramipexole for the treatment of depressive symptoms in patients with Parkinson\u2fffs disease: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Barone","year":"2010","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.biopha.2016.04.026_bib0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1034\/j.1399-5618.2002.01171.x","article-title":"Pramipexole in treatment-resistant depression: a 16- week naturalistic study","volume":"4","author":"Lattanzi","year":"2002","journal-title":"Bipolar Disord."},{"issue":"8","key":"10.1016\/j.biopha.2016.04.026_bib0075","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.pnpbp.2010.07.035","article-title":"Pramipexole for stage 2 treatment- resistant major depression: an open study","volume":"34","author":"Inoue","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.biopha.2016.04.026_bib0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11126-010-9130-6","article-title":"Long- term use of pramipexole in bipolar depression: a naturalistic retrospective chart review","volume":"81","author":"El-Mallakh","year":"2010","journal-title":"Psychiatr. Q."},{"issue":"2","key":"10.1016\/j.biopha.2016.04.026_bib0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00213-004-1809-7","article-title":"The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors","volume":"175","author":"Siuciak","year":"2004","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.biopha.2016.04.026_bib0090","first-page":"493","article-title":"Mechanism of synergistic action following co- treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats","volume":"58","author":"Rogoz","year":"2005","journal-title":"Pharmacol. Rep.: PR"},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2011.12.014","article-title":"Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice","volume":"677","author":"Schulte-Herbr\u00fcggen","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2016.04.026_bib0100","first-page":"173","article-title":"Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A\u2fffmediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor","volume":"26","author":"Edwards","year":"2002","journal-title":"Alcohol.: Clin. Exp. Res."},{"issue":"8","key":"10.1016\/j.biopha.2016.04.026_bib0105","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nn.2592","article-title":"Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors","volume":"13","author":"Higley","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2016.04.026_bib0110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2016.04.026_bib0120","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.biopha.2016.04.026_bib0125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.biopha.2016.04.026_bib0130","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.biopha.2016.04.026_bib0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2014.03.053","article-title":"Opioid\/NMDA receptors blockade reverses the depressant-like behavior of foot shock stress in the mouse forced swimming test","volume":"735","author":"Haj-Mirzaian","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.04.026_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2015.11.009","article-title":"Involvement of N-methyl-d-aspartate receptors in the antidepressant-like effect of 5-hydroxytryptamine 3 antagonists in mouse forced swimming test and tail suspension test","volume":"141","author":"Kordjazy","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2016.04.026_bib0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2016.03.004","article-title":"Involvement of NMDA receptors and l-arginine\/nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test","volume":"122","author":"Ostadhadi","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"19","key":"10.1016\/j.biopha.2016.04.026_bib0150","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1007\/s00213-015-4004-0","article-title":"Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests","volume":"232","author":"Haj-Mirzaian","year":"2015","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2016.04.026_bib0155","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0165-0173(00)00018-7","article-title":"Roles of NMDA receptor activity and nitric oxide production in brain development","volume":"32","author":"Contestabile","year":"2000","journal-title":"Brain Res. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2016.04.026_bib0160","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","article-title":"NO as a signalling molecule in the nervous system","volume":"135","author":"Esplugues","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(03)00306-9","article-title":"Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-d-aspartate receptors and the l-arginine-nitric oxide pathway","volume":"343","author":"Mantovani","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2016.04.026_bib0170","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00213-006-0326-2","article-title":"Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects","volume":"185","author":"Joca","year":"2006","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2016.04.026_bib0175","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbr.2005.06.031","article-title":"Effects of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway","volume":"165","author":"Kaster","year":"2005","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.biopha.2016.04.026_bib0180","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.euroneuro.2003.08.010","article-title":"Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test","volume":"14","author":"Harkin","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.04.026_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2016.03.034","article-title":"Involvement of nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tropisetron and ondansetron in mice forced swimming test and tail suspension test","author":"Haj-Mirzaian","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.04.026_bib0190","first-page":"1","article-title":"Involvement of NO\/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test","author":"Ostadhadi","year":"2016","journal-title":"Naunyn-Schmiedeberg\u2fffs Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YCO.0b013e3280117733","article-title":"Animal models of mood disorders: recent developments","volume":"20","author":"Cryan","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.biopha.2016.04.026_bib0200","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejphar.2015.06.030","article-title":"Elevated level of nitric oxide mediates the anti- depressant effect of rubidium chloride in mice","volume":"762","author":"Kordjazy","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.04.026_bib0205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/1440-1681.12518","article-title":"Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice","volume":"43","author":"Ostadhadi","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2016.04.026_bib0210","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Th\u00e9r."},{"key":"10.1016\/j.biopha.2016.04.026_bib0215","first-page":"1","article-title":"Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl d-aspartate and opioid receptors","volume":"14","author":"Haj-Mirzaian","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2007.08.045","article-title":"The antidepressant effects of curcumin in the forced swimming test involve 5 -HT 1 and 5-HT 2 receptors","volume":"578","author":"Wang","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.04.026_bib0225","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2014.11.016","article-title":"Dopamine D2\/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test","volume":"279","author":"Li","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejphar.2007.04.028","article-title":"Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor","volume":"568","author":"Dhir","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"2\u2fff3","key":"10.1016\/j.biopha.2016.04.026_bib0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245227","article-title":"Dopamine and depression","volume":"91","author":"Brown","year":"1993","journal-title":"J. Neural Transm.\/Gen. Section JNT"},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-3223(92)90137-O","article-title":"Role of the dopaminergic system in depression","volume":"32","author":"Kapur","year":"1992","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.biopha.2016.04.026_bib0245","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1472-8206.2004.00287.x","article-title":"Dopamine, depression and antidepressants","volume":"18","author":"Dailly","year":"2004","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2016.04.026_bib0250","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(93)90257-I","article-title":"Depletion of mesolimbic dopamine during behavioral despair: partial reversal by chronic imipramine","volume":"242","author":"Rossetti","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2016.04.026_bib0255","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0924-977X(00)00079-1","article-title":"The antidepressive-like effect of oxcarbazepine: possible role of dopaminergic neurotransmission","volume":"10","author":"Joca","year":"2000","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2016.04.026_bib0260","first-page":"471","article-title":"Synergistic effect of pramipexole and sertraline in the forced swimming test","volume":"51","author":"Maj","year":"1998","journal-title":"Pol. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0265","first-page":"1","article-title":"Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495)","volume":"4","author":"Shopsin","year":"1978","journal-title":"Neuropsychobiology"},{"issue":"2","key":"10.1016\/j.biopha.2016.04.026_bib0270","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-0327(81)90044-6","article-title":"Bromocriptine and imipramine in endogenous depression: a double-blind controlled trial in out-patients","volume":"3","author":"W\u00e6hrens","year":"1981","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.biopha.2016.04.026_bib0275","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainres.2012.03.029","article-title":"Interactions between NMDA and dopamine receptors: a potential therapeutic target","volume":"1476","author":"Wang","year":"2012","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.biopha.2016.04.026_bib0280","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1460-9568.2011.07949.x","article-title":"Striatal NTS1, dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release\u2fffa dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat","volume":"35","author":"Ferraro","year":"2012","journal-title":"Eur. J. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2016.04.026_bib0285","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1523\/JNEUROSCI.20-11-04011.2000","article-title":"Intracellular modulation of NMDA receptor function by antipsychotic drugs","volume":"20","author":"Leveque","year":"2000","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2016.04.026_bib0290","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1074\/jbc.M511608200","article-title":"Fyn is required for haloperidol- induced catalepsy in mice","volume":"281","author":"Hattori","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2016.04.026_bib0295","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0896-6273(02)00859-0","article-title":"A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission","volume":"35","author":"Kotecha","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2016.04.026_bib0300","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2015.12.006","article-title":"The involvement of NMDA receptor\/NO\/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test","volume":"612","author":"Khan","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0305","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2008.08.033","article-title":"Antidepressant-like effect of folic acid: Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway","volume":"598","author":"de Souza Brocardo","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0310","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0315","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1300.016","article-title":"Glutamate and depression","volume":"1003","author":"Paul","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2016.04.026_bib0320","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00213-009-1609-1","article-title":"NMDA receptor\/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test","volume":"206","author":"Ghasemi","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2016.04.026_bib0325","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-009-1609-1","article-title":"NMDA receptor antagonists augment antidepressant- like effects of lithium in the mouse forced swimming test","author":"Ghasemi","year":"2009","journal-title":"J. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2016.04.026_bib0330","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rog\u00f3\u017c","year":"2002","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.biopha.2016.04.026_bib0335","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/sj.npp.1301039","article-title":"Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic-and antidepressant-like effects in mice","volume":"31","author":"Boyce-Rustay","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0340","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mam.2004.02.010","article-title":"Nitric oxide in brain: diffusion, targets and concentration dynamics in hippocampal subregions","volume":"25","author":"Ledo","year":"2004","journal-title":"Mol. Aspects Med."},{"issue":"6","key":"10.1016\/j.biopha.2016.04.026_bib0345","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1471-4159.2006.03988.x","article-title":"Nitric oxide, cell bioenergetics and neurodegeneration","volume":"97","author":"Moncada","year":"2006","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.biopha.2016.04.026_bib0350","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1097\/00001756-200011270-00022","article-title":"Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice","volume":"11","author":"da Silva GdL. Matteussi","year":"2000","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.biopha.2016.04.026_bib0355","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0028-3908(03)00030-3","article-title":"Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors","volume":"44","author":"Harkin","year":"2003","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002139900316","article-title":"Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats","volume":"149","author":"Yildiz","year":"2000","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2016.04.026_bib0365","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbr.2005.11.023","article-title":"Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice","volume":"168","author":"Almeida","year":"2006","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0370","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2007.05.002","article-title":"Possible involvement of l-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride","volume":"569","author":"Kulkarni","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"04","key":"10.1016\/j.biopha.2016.04.026_bib0375","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S1461145705005316","article-title":"Involvement of nitric oxide\u2fffcGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test","volume":"8","author":"Kaster","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2016.04.026_bib0380","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.pnpbp.2007.02.008","article-title":"Involvement of l-arginine\u2fffnitric oxide\u2fffcyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice","volume":"31","author":"Dhir","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.biopha.2016.04.026_bib0385","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.euroneuro.2007.07.011","article-title":"Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test","volume":"18","author":"Ghasemi","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2016.04.026_bib0390","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(02)00312-1","article-title":"Antidepressant-and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice","volume":"140","author":"Volke","year":"2003","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.biopha.2016.04.026_bib0395","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0005-2728(99)00024-9","article-title":"Guanylate cyclase and the\u2fff NO\/cGMP signaling pathway","volume":"1411","author":"Denninger","year":"1999","journal-title":"Biochim. Biophys. Acta (BBA)-Bioenerg."},{"issue":"5","key":"10.1016\/j.biopha.2016.04.026_bib0400","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/phrs.1997.0245","article-title":"Anxiolytic and antidepressant properties of methylene blue in animal models","volume":"36","author":"Eroglu","year":"1997","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2016.04.026_bib0405","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiol. Rev."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216302050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216302050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:29:39Z","timestamp":1788877779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216302050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":81,"alternative-id":["S0753332216302050"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.04.026","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant effect of pramipexole in mice forced swimming test: A cross talk between dopamine receptor and NMDA\/nitric oxide\/cGMP pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}